Skip to main content
. Author manuscript; available in PMC: 2018 Jun 21.
Published in final edited form as: ACS Chem Neurosci. 2017 Feb 16;8(6):1262–1278. doi: 10.1021/acschemneuro.6b00399

Table 2.

Summary of the effects of fasting and melanocortin (MC) receptor agonism on hormone and cytokine levels from the literature (Lit.) and the current study. Results from fasting and melanocortin (MC) agonism are from the literature with citations referenced directly to their right. A ? mark indicates conflicting results. Results from 5 nmol CJL-1-14 and CJL-1-87 treatments are summarized from the current study. In the current studies, the significance of treatment compared to saline treatment is indicated such that one arrow is p<0.05, two arrows is p<0.01, and three arrows is p<0.001.

Hormone Fasting from Lit. Fasting Citations MC Agonism from Lit. MC Agonism Citations CJL-1-14 (Current Study) CJL-1-87 (Current Study)
Insulin 72, 94 80–82 ↓↓↓
C-Peptide 72, 83, 84, 94 80–84 ↓↓ ↓↓↓
Leptin 72, 94 81, 82 ↓↓ ↓↓↓
GIP 85, 95 85 ↓↓ ↓↓↓
Ghrelin 72, 96 ? ↑ 92 ↑↑↑
IL-6 97 ? ↓ 88–91 ↑↑↑ ↑↑↑
Resistin 72, 93 ? 86, 87 ↓↓